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Abstract 
In this study, the usage of 3D printed polycaprolactone (PCL) constructed supports with non-
uniform internal structure and varied mechanical properties was applied to cartilage tissue 
engineering (CTE) operations. The fabricated structure can be utilized as structural support for 
engineering functional tissue grafts of clinically relevant size, such as auricular tissue. The design 
of auricular scaffolds using Computed tomography (CT scan) images with computer-aided design 
(CAD) was performed.  The feasibility of using 3-dimensional (3D) printing methods for fabrication 
of such structures was investigated to mimic the mechanical characteristics of human auricular 
cartilage. A series of mechanical tests were performed to calculate the modulus of elasticity of 
printed structures. A range of tensile moduli for the uniform internal structures of between 4 – 
13 MPa, which is close to human articular tissue (16 ± 3.3 MPa), was obtained. Moreover, a three-
dimensional finite element analysis (FEA) was conducted for evaluating a complete stress analysis 
of an ear structure. The deformation responses of the 3D simulation mimicked the compression 
behaviour of 3D printed ear structure. 
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1. Introduction  
1.1. Microtia 
Microtia, a Greek word which means ‘little ear’, is a well-known genetic disorder in which babies are 
born without or with an under-developed ear[1].  Microtia can show up in isolation or as a feature of 
other disorders such as Treacher Collins or  Hemifacial micro-somia syndrome[1]. Defects like these 
are also common parts of isotretinoin[2] and thalidomide[3] embryopathies. Therefore, they might be 
of special concern in studies of other possible teratogenic aspects, such as drugs. In its most severe 
shape, microtia is represented by total or almost complete lack of external ears[4]. Currently, the 
common surgical technique for remaking of ear  is by utilizing autologous rib cartilage[5]. The first step 
to create a framework includes modelling and connecting  together the rib cartilage to imitate a new 
ear[5]. This technique has some  complications; including the necessity to delay any surgery until the 
patient is at an age of between 6 to 10 years[5]. In order to offer earlier surgical intervention and avoid 
removing costal cartilage, currently alloplastic materials are being utilized to reconstruct the ear. 
There are a number of advantages of using synthetic materials; such as mass production with different 
predesigned sizes and shapes, as well as decreasing the demand on donors[6].  The bulk properties 
and surface of the synthetic ear should be proper to allow for good tissue angiogenesis and 
integration[7]. The mechanical property of the material is one of the most important specifications of 
the material. Studies show that a synthetic material should have an elastic modulus similar to the 
tissue it is substituting, to avoid mechanical disparity[8]. 
1.2. 3D printing of ear structure 
The human outer ear consists of primarily fat tissue and elastic cartilage in a complex organization 
that is difficult to be reconstituted [9]. In external ear regeneration, reconstruction of the ear  auricular 
tissue has been considered by using a combination of tissue engineering and bioprinting approaches  
(extrusion based printing) [10]. Researchers have used a rapid prototyping technology to fabricate 
ear-shape moulds to aid in ear reconstruction [11]. Extrusion based 3D printing technology has also 
been applied for 3D printing cell-laden structures in an external ear shape. However, mimicking the 
structural and mechanical characteristics of the human outer ear, which is the key to re-establishing 
the biological functions, imposes substantial challenges like cartilage formation, keeping the shape of 
structure during in vitro, and the scaffold degradation speed [12][13].  In this project, for the first time, 
the effect of non-uniform internal structure on the mechanical properties of different sections of an 
ear scaffold is investigated. 
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1.3. Additive manufacturing in 3D printing 
Additive manufacturing (AM) has emerged as one of the standard fabrication techniques in the past 
three decades. In this method, components are built by generating a 3D model using a computer-
aided design (CAD) and adding materials in a layer-by-layer fashion to make the final model.  Printing 
can be done without using any additional equipment or tools like fixtures, coolants, or cutting tools 
which are needed in the traditional manufacturing techniques. Moreover, in the AM techniques, the 
model can be custom designed and optimised before starting the manufacturing [14].  It also allows 
easier control on process parameters, such as strand alignment, strand spacing and size, and offers 
multipurpose pore geometry, reproducibility, and 100% pore-interconnectivity without using 
solvents[15]. Subsequently, it helps users to modify load-bearing and mechanical properties of the 
structures to imitate the architecture of tissues in a way which is not possible with ordinary 
manufacturing systems[16][17]. 
1.4. Scaffolding in tissue engineering 
Bioprinting has been extensively used for fabrication of scaffolding structures for specific tissue 
constructs. A scaffold should be able to seamlessly integrate with its surrounding tissue and supply 
the initial 3D structural support that enables cell attachment, growth, proliferation, differentiation 
and forming their extracellular matrix (ECM). This requires the structure to be able to simulate the 
framework and morphology of the natural tissue [18]. Research has shown that isolated cells without 
initial structural support are unable to form physiologically and mechanically appropriate neotissues 
[19]. Therefore, 3D porous bioresorbable scaffolds are being used as a practical biofabrication 
approach to tissue-engineered constructs. Extrusion based 3D printing is one of the popular methods 
in bio-printing to fabricate scaffolds by extruding small filaments or streams of polymers which solidify 
instantly to shape layers. 
1.5. Internal porous structures 
Scaffold material and internal porous structure and mechanical properties can play important roles in 
regenerating structure, tissue type, and function[20]. Many studies have been done on the effects of 
porosity and pore size of the structure[20][21] which show that the porosity of the scaffold is 
specifically related to its pore geometrical arrangement , strand orientation (SO), strand spacing (SS), 
and strand size (SZ)[22][16] [23]. Olubamiji et al. conducted a research to observe the effects of pore 
geometrical configuration on mechanical properties and porosity of 3D printed PCL structure. They 
showed that the pore geometrical configurations of SS, SZ and SO scaffolds have an effect on tensile 
and compressive moduli, and on the porosity of 3D printed PCL structures, and exhibited an inverse 
linear relationship between porosity and mechanical properties. Also the comparison of the results 
with a real human articular cartilage indicated that the 3D-printed PCL scaffold could have the 
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promising potential for imitating the mechanical behaviour of actual human articular cartilage. [24]. 
In another research, the influence of molecular weight on mechanical properties of biomaterials and 
structures was investigated and revealed that by increasing the molecular weight, the strength or 
mechanical properties were increased; such as yield stress, elastic modulus, and fracture toughness 
of different materials ][25][26][27].  
1.6. Polycaprolactone in Tissue Engineering 
Different types of biomaterials, such as metals, composites, bio-ceramics, and biopolymers have been 
used in tissue engineering to provide 3D structural support. PCL is one of the materials that have 
received a lot of attention, in particular in engineering large tissue constructs. PCL is a biocompatible 
and biodegradable semicrystalline polymer which is applied in a range of biomedical applications. 
Since constructing 3D scaffolds that are capable of imitating biological and mechanical properties of 
human articular cartilages is one of the main challenges in cartilage tissue engineering (CTE)[28], it is 
worthwhile to deeply consider how to optimize the mechanical properties of the printed scaffolds 
while there is little research done in this field in CTE process [24]. Although most researchers are 
concentrating on PCL-based hybrid constructs for CTE applications, this project focuses on the PCL 
[29].  
PCL is composed of a polyester hexanoate backbone, and made by chain-growth polymerization of ε-
caprolactone by using a catalyst like stannous octoate (Fig.1)[30]. PCL  is considered to be semi-
crystalline to a degree close to 69% [31]. This material is extremely soluble in dichloromethane, 
benzene, carbon tetrachloride, toluene, cyclohexanone, chloroform, and 2-nitropropane; lightly 
soluble in acetone, 2-butanone, ethyl acetate, dimethylformamide and acetonitrile; and insoluble in 
diethyl  ether, petroleum ether, alcohols and water [32]. PCL is biodegradable, with a degradation 
profile ranging from a few months to a few years, depending on its molecular weight and the degree 
of crystallinity. One use of PCL is in biomedical practices because of its soft and hard-tissue 
compatibility. For instance, it has been used for resorbable structures, drug delivery systems, and 
scaffolds for tissue engineering [33]. This material has a low rate of hydrolytic degradation, which is 
useful for long term demands [32]. PCL is also a good material for supporting cell attachments, 
proliferation, and can also be used as a matrix material for cell culture[34].  Table 1 illustrates the 
material properties of PCL within its different molecular weights. 
 
Fig. 1. Polymerization of ε-caprolactone [30] 
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Table 1. Properties of PCL[32] 
Properties Range 
Average molecular weight (Mn/g mol-1) 530-630 000 
Density (ρ/g cm-3) 1.071-1.200 
Glass transition temperature (Tg/°C) (-65)-(-60) 
Melting temperature (Tm/°C) 56-65 
Decomposition temperature (/°C) 350 
Inherit viscosity (ηinh/cm3 g1) 100-130 
Intrinsic viscosity (η/cm3 g1) 0.9 
Tensile strength (σ/MPa) 4-785 
Young modulus (E/GPa) 0.21-0.44 
Elongation at break (ɛ/%) 20-1000 
1.7. Finite Element Analysis (FEA) 
Finite Element Analysis (FEA) is a method of simulating Computer aided design (CAD) objects to predict 
deformation and stresses which has become very popular in research, and its goal is accomplishing 
accurate results at adequate speed for virtual model or immediate simulation [35][36]. To date, the 
majority of simulation works were not accurate enough and mostly concentrated on the visual effects. 
Moreover, in tissue engineering area, simulations were done in linear methods which are fast but only 
precise for minor deformations because of very compound nonlinear viscoelastic behaviour of human 
tissues [37]. Addressing practical issues in joint mechanics will require accurate geometric data, 
advanced numerical strategies to calculate the continuum conditions demonstrating the soft tissue 
conduct of the structures in the articulating joint, and precise values for the related material 
parameters [38]. In this project, mechanical properties of printed scaffolds with different internal 
structures were measured by running static tensile, compression tests, and then these parameters 
were used for 3D simulation of articular CAD model to predict the deformation and stresses. 
2. Materials and Methods 
2.1. Design and fabrication of PCL scaffolds  
2.1.1. Preparation of samples for 3D printing 
PCL with molecular weight of 45 000g mol-1 (PCL45) and Pluronic F-127 were purchased from Sigma 
Aldrich. To fabricate scaffolds, the PCL was introduced into the high-temperature syringe and 
dispensed through a tubular steel needle head. Cubic and cylindrical samples with different strand 
sizes were 3D printed and their tensile and compression mechanical properties were measured. A 
KIMM 3D printer (Fig. 2) was used to print the PCL structures. Desired structures were modelled using 
SolidWorks 2016 software, and the final model was saved in STL format. The STL files were then 
exported into Repetier (V2.0.5) and sliced into 21 layers, with each layer height of 0.3mm and 0°-90° 
patterns (Fig. 5).  
5 
 
 
                  
    3D Bio-Plotter     KIMM Printer 
Fig. 2. 3D Bio-Plotter and KIIM Printers 
2.1.2. Pressure and Speed Tuning for 3D printing 
The KIMMSPS 1000 extrusion 3D printer is capable of extruding fibres varying from 100 µm to 500 µm 
at a minimum resolution down to 1 µm. This 3D printer is working in concert with three working 
appliances, with an extra attachment for printing in the rotating axis to make scaffolds in the shape of 
cylinders and tubes. The machine’s temperature can also be adjusted for melt extrusion printing. The 
building process for 3D plotting is dependent on a large number of parameters; especially printing 
pressure and speed. It is difficult to calculate all of these in advance for a new material. Therefore, a 
series of experiments has to be carried out to find the right settings. One of the best options for finding 
the appropriate printing Pressure and Speed is using the Pressure Tuning Parameter and Speed Tuning 
Parameter. Under Pressure Tuning Parameter, a fixed Speed was selected, as well as the minimum 
and maximum pressure. Also, Under Speed Tuning Parameter, a fixed Pressure was selected, as well 
as the minimum and maximum speed. In this process 5 strands were printed within the defined range.  
2.1.3. 3D modelling of cubic and cylindrical mechanical samples 
The aim of this project is to investigate the relationship between the internal layout of a 3D printed 
structure and the mechanical properties. Therefore, two types of cubic and cylindrical samples were 
modelled using SolidWorks. When the model was created it was required to be sliced and converted 
to G-Code format for 3D printing. For tensile tests, two types of samples with uniform and non-
uniform internal structures with external dimensions of 10LX6WX2H mm were modelled: affording 
uniform structures with strand sizes (SS) of 1mm (S1), 1.5mm (S1.5), and 2mm (S2), and  non-uniform 
internal structures with combinations of strand sizes of 2mm and 1mm (S2S1), 2mm and 15mm 
(S2S15), 2mm and 15mm and 1mm (S2S15S1) (Fig. 11). For compression tests, Cylindrical models with 
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15mm Diameter, 5mm Height, and strand sizes of S1, S1.5, and S2 for uniform structures, and S2S1, 
S2S1.5, and S2S1.5S1 for non-uniform structures were created (Fig. 12). 
 
2.1.4. Modeling and printing of ear structure 
The next step in this project was using 3D printers to fabricate ear scaffolds with uniform and non-
uniform internal structures which could mimic the mechanical properties of an actual human articular 
structure. The correct shape of a scaffold construct is obtained from a human ear by processing 
computed tomography (CT scan) data in Materialise Mimics (3D Medical Image Processing Software). 
In addition, ear scaffolds were designed using SolidWorks and sliced using repetier. As the ear scaffold 
had a complex structure, in some areas support material was required; therefore, envision bio-plotter 
(Fig. 2) with two nozzle heads were used for 3D printing of ear scaffolds. Two different types of ear 
scaffolds were designed: a uniform internal structure and non-uniform internal structure (Fig. 13). 
Since with auto-slicing of the ear structures there was no control on their internal layout, the models 
were post-processed and converted to sets of lines sitting on top of each other in 0-90 orders forming 
the ear scaffolds. In this project two types of ear scaffolds were 3D printed: uniform internal structure 
with strand sizes of 1mm, 1.5mm and 2mm, and non-uniform internal structure with strand sizes of 
1mm and 1.5mm.  
The distances between the strands of the structures were selected based on Lee et al,  where 3D 
printed PCL structures with different strand spacings between 1.0 and 1.2 mm were able to reach 
tensile moduli similar to the tensile modulus of the auricular cartilage (16 ± 3.3 MPa)[39]. Therefore, 
in this project, the influence of the pattern designs with strand spacings of 1.0, 1.5 and 2.0 mm on the 
mechanical properties like the tensile modulus and the compression modulus was investigated. 
Hence, a range of tensile moduli for the uniform internal structures between 4 – 13 MPa was obtained. 
Structures with 3 different grid sizes were printed and then, based on the mechanical properties 
results, grid sizes of 1 and 1.5 were chosen to print the hard and soft segments of the ear. The soft 
segment of the ear was printed in both grid sizes, while the hard segment was printed only with the 
grid size of 1mm. 
As mentioned earlier, because of the complexity of the ear structure, support materials were required 
to be 3D printed under some areas of the scaffold.  The appropriate support material should be bio-
compatible and easily removable without affecting the mechanical properties of the ear structure. 
Therefore, 20 wt. % pluronic acid f127, a bio-compatible and water soluble support material, was 
chosen (Fig. 20). 
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2.2.  Mechanical Test of 3D printed structures 
2.2.1. Mechanical testing of 3D printed PCL structure  
In these experiments two types of uniaxial static tensile and compression tests were performed using 
a Shimadzu EZ mechanical tester. For each test, three samples with similar internal and external 
structures were tested and their standard deviations were calculated using Microsoft excel.  
In compression tests, cylindrical samples were tested with 500N uniform pressures at a compression 
rate of 10mm/min. Also, for tensile tests, the cubic samples were stretched to their break point at a 
rate of 10mm/min (10mm on each side were used for connection to clamps). 
2.2.2. Dynamic Mechanical Analysis (DMA) 
As PCL is a viscoelastic material, DMA tests were performed in order to investigate the relationship 
between elasticity and plasticity of the structures during deformation. Therefore, 60X6x2mm samples 
with different strand sizes were modelled and then tested at room temperature using a TA 
instruments Q800 DMA with Dual cantilever fixture clamps (Fig. 3). For all tests, multi-strain method 
with frequency of 1HZ and amplitude range from 2 to 5000µm were used.  
 
Fig. 3. TA instruments Q800 DMA with Dual cantilever fixture clamps 
2.2.3. Mechanical Test of ear scaffold 
The ear structure was divided into 6 regions and two types of compressive mechanical tests were 
performed on each region using a Shimadzu EZ mechanical tester with 5mm diameter press (Fig. 4).   
In the first experiment, a full compressive test was performed and a stress-strain graph was plotted 
from which the modulus of elasticity of the scaffold was measured; from the initial region of the graph. 
The second experiment was a recovery test measuring the mechanical properties of the ear structure 
by applying 20 cycles of compression with 50N Force.  
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2.3. Finite element analysis 
After all the mechanical properties of the PCL samples were measured and their modulus of elasticity 
was extracted, finite element analysis (FEA) was performed using a SolidWorks simulation nonlinear 
method. In this experiment,  attempts were made to predict the mechanical behaviour of the 
structures under different types of loadings. Therefore, two types of tensile and compression 
simulations were performed in these analyses with the Poisson’s ratio of 0.3  which was measured by 
an optical method that was explained by Jurvelin et al. [40]. 
Mesh convergence is one of the issues in computational mechanics that effects the accuracy of the 
results. In this project, for FEA analysis, Solid Curvature-based mesh with 4 points Jacobina points were 
selected. To be able to mimic the real 3D printed ear structure and to prevent stress convergence 
errors during simulation this type of mesh was selected which creates more mesh elements in higher 
curvature areas automatically without need for mesh control. Also 0.2mm was chosen for the element 
size which noticeably increased the processing time but had two advantages: 
1- To help us getting more accurate results closer to the mechanical tests. 
2- Prevent stress convergence specially on the corners.  
Also, the sharp corners of the structure were modified, by reshaping them to sphere shape to prevent 
stress convergence. 
 
To be able to simplify the analysis, the following presumptions were made: 
1. The PCL material of structures was assumed to be homogeneous, non-linear. 
2. The spreading of the temperature throughout analysing of the scaffolds is uniform. 
3. Throughout the FEA analysis, it was assumed that the Poisson ratio is constant. 
4. No rotation or translation was allowed for all nodes in contact with the clamps. 
5. The contact elements between filaments were assumed to be fully bonded. 
6. The filaments diameter is exactly 0.3mm. 
7. The filaments are assumed to be straight lines. 
In all tensile and compression tests, the models were pulled or pressed until the stage of fracture. The 
ear model was also 3D CAD simulated by dividing it into six separate sections and compression load 
was applied on each section (Fig. 4). For each sample the maximum Von Mises stress required to 
deform the scaffolds was calculated. 
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Fig. 4. Six sections of ear scaffold for Mechanical tests and CAD simulations 
3.  Results and Discussion 
Fig. 5 shows the sliced STL structure using Repetier (V2.0.5). As mentioned before, each structure was 
sliced into 21 layers with layer height of 0.3mm and 0°-90° patterns 
        
Fig. 5. Generated sliced pattern for 3D printing 
 
3.1. Pressure and Speed Tuning for 3D printing 
Table 2 and Table 3 illustrate the pressure and speed parameters that were used in our 10 tuning 
prints. 
Table 2.Pressure tuning parameters 
 
Test 
Pressure 
(bar) 
Speed 
(mm/s) 
Temperature 
(°C) 
Pressure 
Tuning 
Pressure 1 1 2 120 
Pressure 2 1.38 2 120 
Pressure 3 1.75 2 120 
Pressure 4 2.0 2 120 
Pressure 5 2.5 2 120 
 
Table 3.Speed tuning parameters 
 
Test 
Pressure 
(bar) 
Speed 
(mm/Sec) 
Temperature 
(°C) 
Speed 1 2.0 2 120 
10 
 
Speed 
Tuning 
Speed 2 2.0 6.25 120 
Speed 3 2.0 7.5 120 
Speed 4 2.0 8.75 120 
Speed 5 2.0 10 120 
Table 4 and  
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 show the effects of pressure and printing speed on printing quality respectively. The results 
show that by increasing the pressure, the printed thickness of printed lines increases while by 
increasing the speed, its thickness decreases. 
 
 
 
 
 
Table 4. Microscope images of Pressure tuning prints 
Test  
Pressure 
(bar) 
Speed 
(mm/s) 
Temperature 
(°C) 
Thickness
(mm) 
Pressure 
1 
 
1 10 120 0.175 
Pressure 
2 
 
1.38 10 120 0.138 
11 
 
Pressure 
3 
 
1.75 10 120 0.171 
Pressure 
4 
 
2.13 10 120 0.273 
Pressure 
5 
 
2.5 10 120 0.276 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Microscope images of Speed tuning prints 
Test  
Pressure 
(bar) 
Speed 
(mm/s) 
Temperature 
(°C) 
Thickness 
(mm) 
Speed 
1 
 
2.0 5 120 0.291 
Speed 
2 
 
2.0 6.25 120 0.239 
12 
 
Speed 
3 
 
2.0 7.5 120 0.131 
1Spee
d 4 
 
2.0 8.75 120 0.114 
Speed 
5 
 
2.0 10 120 0.191 
 
3.2. 3D Printed Single Layer Structure  
After finding the optimum printing speed (5mm/s) and Pressure (2.5 bar), in the next stage 
10X10x10mm single layer squares with different line spacings (1mm, 2mm, 2.5mm) and angles (0°, 
45°, 60°) were printed. Table 6 demonstrates nine different single layer 3D printing as well as 
microscope imaging of PCL structure with different internal shapes (0°, 45°, 60°, and 1, 2, 2.5 mm 
distance) under conditions of: the Pressure: 2.5bar, Speed: 5mm/s, thickness: 0.3mm, and Layer 
height: 0.3 mm.  
Table 6. Microscope printing images of single layer prints with different internal structures (Scale bar=2mm) 
Test  
Pressure 
(bar) 
Speed 
(mm/s) 
Tempe
rature 
(°C) 
Layer 
Height 
(mm) 
Angle 
(°) 
Distance 
(mm) 
Test 
1 
 
2.5 5 130 0.3 45 2 
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Test 
2 
 
2.5 5 130 0.3 0 2 
Test 
3 
 
2.5 5 130 0.3 60 2 
Test 
4 
 
2.5 5 130 0.3 0 1 
Test 
5 
 
2.5 5 130 0.2 45 1 
Test 
6 
 
2.5 5 130 0.3 60 1 
Test 
7 
 
2.5 5 130 0.3 0 2.5 
Test 
8 
 
2.5 5 130 0.3 60 2.5 
14 
 
Test 
9 
 
2.5 5 130 0.3 45 2.5 
3.3. 3D printed Single & Multilayer Structure  
At the next stage, a double line test print with the pressure (P) of 2.5 bar and speed (S) of 5 mm/Sec 
was performed and the print was checked under the microscope to ensure that the print had the 
desired specifications (0.3 mm thickness (T), 2 mm distance (D)). By looking at Fig. 6, it can be seen 
that by using the above speed and pressure, the desired thickness was achieved for a 2 layers print.  
 
Fig. 6. Test11: Pressure: 2.5 bar, Speed: 5mm/Sec, thickness: 0.3mm 
Next, multi-layer printing was performed with the selected speed and pressure. During this 
experiment, in the scaffolds with a larger gap between strands, the lines were sagging before 
solidifying,  therefore, to be able to get straight lines a fan was used to cool down the filament as soon 
as they were printed; which improved the printing quality considerably (Fig. 7).  
 
 
A B 
15 
 
                                  
Fig. 7. The effect of using a fan cooling system on the construction of 3D printed sample (A: no fan, B: fan cooled 3D 
printed structure) 
3.4. Optical Microscopy 
The optical images of printed PCL scaffolds were taken by using a Leica Stereo microscope (M205A). 
The microscope images of PCL scaffolds are shown in Fig. 8. According to the figures, in all structures, 
the thickness of filaments is 0.3mm and the scaffolds have the strand sizes of 1mm, 1.5mm, and 2mm 
respectively. 
 
 
S1 
S1.5 
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Fig. 8. The microscope images of PCL scaffolds with diverse strand size configurations 
 
3.5. 3D modelling and printing of mechanical samples 
The major problem with slicing software like Repetier is that they are ideal to be used for fuse 
deposition modelling (FDM) method and not bio-purposes, and with auto-slicing there was no control 
of the internal distances of the strands. Another problem with the auto-slicing option was the 
traversing problem of the nozzle, which means that, in each layer instead of having one continuous 
line and having one start and one end point, the nozzle was printing each layer randomly (Fig. 9). 
Therefore, to be able to generate 3D mechanical samples with desired pattern, the model was first 
modelled as a cubic or cylindrical block and then post-processed and finally converted to a set of lines 
sitting on top of each other forming the printing pattern (Fig. 10). 
 
 
Fig. 9. Traversing problem of nozzle during 3D printing 
S2 
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Fig. 10. Construction of 3D models 
 
The final 3D design and printed structures are shown in Fig. 11 and Fig. 12. All filaments have the 
thickness of 0.3mm and height of 0.3mm. 
 
 
 
 
 
 
 
 
 
 
A 
B 
S1 
S2 
S1.5 
S2S1 
S2S1.5 
S2S1.5S1 
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Fig. 11. Uniform and non-uniform samples for tensile test – Scale bar=2mm 
 
 
 
 
 
 
 
Fig. 12. Uniform and non-uniform samples for Compression test – Scale bar=2mm 
3.6. 3D modelling and printing of ear structures 
Fig. 13 shows the final 3D model and printing of uniform (A) and non-uniform (B) ear scaffolds.  
A 
B 
S1 S2 S1.5 
S2S1 S2S1.5 S2S1.5S1 
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Fig. 13. Ear scaffold with Uniform (A) and non-uniform (B) internal structure 
3.7. Mechanical testing 
3.7.1. Mechanical testing of PCL structure: performing Static Tensile and Compression 
Measuring and characterizing the material properties 
In both compressive and tensile tests, the force F (N) and deformation d (mm) were recorded, and 
calculated stress and strain values were used to plot the stress–strain graphs. In addition, for each 
structure, modulus of Elasticity was calculated by using the initial linear section of the stress-strain 
curve. In both compression and tensile tests, the PCL scaffolds were elastic and not brittle and 
exhibited linear stress-strain behaviour in a small region followed by a yield point, and strain hardening 
region and finally disrupter in tensile tests.  
A 
B 
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3.7.1.1. Compression and Tensile tests of Uniform Structure 
Fig. 15 (A) and (B) illustrate the initial region of Stress-strain graphs in both tensile and compression 
tests of uniform internal structures. From these graphs the modulus of elasticity was calculated and 
as shown in Table 7, in both compression and tensile tests, the modulus of elasticity of 3D printed 
scaffolds is decreased by increasing the strand size of scaffolds. By changing the strand size from S1 to 
S1.5 the modulus of elasticity decreased 30% in compression and 33% in tensile tests. Also, by 
changing the strand size from S1.5 to S2, the modulus changes 44% in compression and 50% in tensile 
tests. This clearly shows that the strand size significantly affects the mechanical properties of printed 
structures. 
Fig. 15 (A) and (B) also shows that in uniform structures, in both compressive and tensile tests, by 
increasing the strand sizes, less force is required to deform the structures. The moduli of Elasticities 
measured in these experiments are used for defining the mechanical properties of finite element 
analysis of scaffolds. Fig. 14 shows the deformation of a tensile sample (S1). It can be seen that the 
load is distributed uniformly along the sample and the necking and fracture has happened in the 
middle of the structure. This demonstrates that the structure has a uniform stiffness and consequently 
unique mechanical properties along the structure. 
 
      
Fig. 14. Tensile deformation of uniform structure 
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Fig. 15. (A) Initial regions of Tensile Stress-strain Curves of Uniform internal structures; (B) Initial regions of Compressive 
Stress-strain Curves of Uniform internal structures. An example of a complete stress-strain curve is shown at top corner 
of (A) and (B) 
Table 7.Strand sizes and equivalent compressive and tensile modulus of Uniform 3D printed PCL scaffolds. 
 Experimental 
Groups 
Strand Size(mm) Compressive 
Modulus(MPa) 
Tensile 
Modulus(MPa) 
1 S1 11.533±4.42 13±0.99 
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Uniform internal 
structures 
2 S1.5 8.82±3.78 8.78±0.34 
3 S2 5.06±1.83 4.37±0.33 
3.7.1.2. Compression and Tensile tests of Non-Uniform Structures 
Fig. 17 (A) and (B) illustrate the initial region of Stress-strain graphs in both tensile and compression 
tests of non-uniform internal structures. From these graphs the modulus of elasticity was calculated 
and as shown in Table 8, in both compression and tensile tests, the modulus of elasticity of 3D printed 
scaffolds is decreased by increasing the distances between strands of scaffolds which infers that the 
scaffolds with higher porosity have lower modulus of Elasticity and consequently larger elasticity. For 
instance, comparing S2S1 to S2S1.5 structures, it can be seen that the modulus of elasticity has 
decreased by 4% in compressive and 6% in tensile tests while by changing from S2S1.5 to S2S1.5S1 
the modulus of elasticity is changing by 10%  and 19% respectively. Also, in both uniform and non-
uniform structures, by increasing the porosity, less force is required to deform the structure. Fig. 16 
shows the deformation of a non-uniform tensile sample (S2 on the bottom and S1 on top). It can be 
seen that during deformation, first the bottom part of the sample which has larger strand sizes has 
started deforming while the top side has still kept its shape. This demonstrates that the structure has 
a different stiffness and consequently varied mechanical properties in its different regions. 
  
Fig. 16. Tensile deformation of non-uniform structure (S2S1) 
 
23 
 
 
 
Fig. 17. (A) Initial region of Tensile Stress-strain Curves of Non-Uniform internal structures; (B) Initial region of Compressive 
Stress-strain Curves of Non-Uniform internal structures. An example of a complete stress-strain curve is shown at top 
corner of (A) and (B) 
Table 8. Strand sizes and equivalent compressive and tensile modulus of 3D printed Non-Uniform PCL scaffolds. 
 Experimental 
Groups 
Strand Size(mm) 
 
Compressive 
Modulus(MPa) 
Tensile 
Modulus(MPa) 
1 S2S1 54.47±18.21 6.04±0.84 
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Non-Uniform 
internal 
structures 
2 
3 
S2S1.5 52.64±12.56 5.69±1.35 
S2S1.5S1 47.32±16.74 4.03±0.71 
From Table 8, it is obvious that in compression tests, the modulus of elasticity of non-uniform 
structures are significantly higher than uniform structures and this could be the effect of the borders 
that had to be printed to join the different size of strands together (Fig. 12 (part B)). In further studies, 
this issue can be resolved by improving the 3D model of the non-uniform compression samples. 
3.7.2. Dynamic Mechanical Analysis (DMA) test 
In this experiment a series of DMA tests was performed on the uniform and non-uniform structures 
to evaluate the viscoelasticity and the mechanical behaviour of the PCL structures under dynamic 
loads.  
Fig. 18 shows the storage modulus and loss modulus of different types of uniform and non-uniform 
scaffolds. According to the graphs in DMA test, with the increase of strand sizes, the amount of storage 
modulus or stored energy which represents the elastic portion of the structures is decreasing. On the 
other hand, the loss modulus or the energy that is dissipated as heat and demonstrating the viscosity 
of the material is increasing by the increase of the strand sizes of the scaffolds. Also, in all scaffolds 
with the uniform internal structures, by increasing the amount of strain amplitude, the storage 
modulus is increasing while the loss modulus is decreasing.  
In addition, these graphs illustrate that in both uniform and non-uniform structures, by increasing the 
density of the material, the amount of viscoelasticity is increasing which proves the direct impact of 
internal structure on the mechanical properties of the structure. 
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Fig. 18. (A) DMA test results on Uniform internal structures – The relationship between storage modulus and loss 
modulus. (B) DMA test results on non-Uniform internal structures – The relationship between storage modulus and loss 
modulus 
3.8. 3D Printing and Simulation of ear structure 
3.8.1. 3D printing of ear scaffold 
Fig. 19 shows the different types of 3D printed ear scaffolds with uniform internal structures (S1) (A), 
combination of two types of strand sizes (S1.5, S1) (B), and the model and 3D printed 
 structure with 6 different strand sizes (S0.6S 0.8S 1S 1.2S 1.4S 1.6) (C).  
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Fig. 19. Designed model and Printed pours ear scaffolds with (A) S1 Uniform internal structure, (B) S1S1.5 non-uniform 
structure, and (C) S0.6S 0.8S 1S 1.2S 1.4S 1.6mm non-uniform - multi sections internal structure – Scale bar=2mm 
C 
S1 
S1.5S1 B 
A 
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Fig. 20 shows the uses of 20 wt. % pluronic acid f127 as a support material for printing ear structures. 
This support can be easily separated from the structure by either cooling down or being washed by 
water without damaging the 3D printed scaffold. 
 
Fig. 20.Printing Pluronic acid f127 for support material 
3.8.2. Mechanical testing of an ear structure  
3.8.2.1. Compression test 
Fig. 21 illustrates the initial region of compressive Stress-strain graphs in uniform (A) and non-uniform 
(B) ear structures. Table 9, Table 10 shows the compressive modulus in 6 different areas of the uniform 
(S1 in all areas), and non-uniform (s1 in areas 1, 2, 3 and S1.5 in areas 4, 5, and 6) ear scaffolds (Fig.22). 
By comparing the uniform and non-uniform graphs in these tables, it can be seen that by increasing 
the strand sizes in areas 4, 5, and 6, the required force to deform the scaffold has significantly 
decreased. This means that for the same scaffolds, by increasing the strand sizes or porosity of the 
structure, the force required to deform the structure is decreasing significantly. 
Based on these results it can be proven that 3D printing is giving us the ability of changing the internal 
layout of the structure to be able to 3D print an ear scaffold with various mechanical properties to 
mimic the actual human ear structure. 
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Fig. 21. (A) Initial region of compressive Stress-strain Curves of ear scaffold with Uniform (all areas strand sizes=1mm) 
(A) and non-uniform (S1 in Areas 1, 2, 3, and S1.5 in areas 4, 5, 6) (B) internal structures; an example of complete stress-
strain curve is shown at top corner of (A) and (B) 
Table 9. Compression test of Uniform PCL ear scaffolds 
 
area Strand Size(mm) 
Compressive 
Modulus(MPa) 
Ear with uniform 
internal structures 
 
1 
2 
3 
S1 1.59±0.12 
S1 5.10±0.24 
S1 4.43±0.29 
4 S1 6.82±4.74 
5 S1 1.72±0.36 
6 S1 2.33±0.57 
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Table 10. Compression test of Non-Uniform PCL ear scaffolds 
 
area Strand Size(mm) 
Compressive 
Modulus(MPa) 
Ear with non-uniform 
internal structures 
 
4 S1.5 1.63±0.41 
5 S1.5 1.15±0.61 
6 S1.5 0.56±0.37 
 
      
Fig. 22. Compression test of ear scaffold in different regions 
3.8.2.2. Recovery Tests     
Fig. 23 and Fig. 24 illustrate the Force (N)-Displacement (mm) graphs for uniform and non-uniform 
scaffolds respectively.  In all samples, a large hysteresis in the first cycle is followed by significantly 
smaller ones, indicating that most of the hysteresis occurred in the first cycle. Furthermore, force 
softening, which appears as an increase in the strain of the samples, decreased at higher number of 
cycles. The results indicate that hysteresis and force softening decrease by increasing the compression 
cycles. 
Comparing areas 1, 2 and 3, area 1 shows significantly better elastic properties with higher strain, 
smaller hysteresis as well as identical loading/unloading paths with minimal variations. Better 
elasticity in area 1 could be attributed to its more compact structure. Areas 4, 5 and 6 have been 
printed in two different grid sizes of 1.5mm. There is not any significant difference on the compression 
curves of area 4 and 5 by increasing the grid size.  On the other hand, area 6 with larger grid size shows 
perpetual force softening, increased by number of cycles, which is considerably less evident in its 
smaller grid size.  This can be due to the weaker structure of area 6, which became even weaker when 
the structure is printed in larger grid size. Area 4 shows smaller strain at 50N force compared with 
areas 5 and 6, which is due to its compact printed structure compared with other areas. Area 5 shows 
smaller force softening compared with the other areas. Generally, area 1 shows better elastic 
behaviour at 50N force, due to having  a more compact structure and more layers at that area. These 
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graphs show that the regions 1, 2, and 3, which are harder, have more uniform structures with better 
elastic recoveries compared with softer regions. These graphs also show that the strain is increasing 
when the strand sizes increase. In conclusion, the softer regions are having a much more non-uniform 
strain behaviour compared with regions with smaller strand sizes, which are stiffer. 
 
 
 
Fig. 23. Recovery tests (20 Cycles and 50N) on the Uniform internal structure (all areas strand sizes=S1) 
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Fig. 24. Recovery tests (20 Cycles and 50N) on the non-uniform internal structure (S1 in areas 1, 2, 3, and S1.5 in areas 4, 
5, 6) 
3.9. Finite Element Analysis (FEA) of PCL structures and correlation of 
results with mechanical test 
Fig. 25 and Fig. 26 show the nonlinear simulation results for tensile and compressive samples for 
uniform and non-uniform internal structures. All stress results for tensile and compression tests are 
available for each element under different loading conditions.  
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3.9.1. Finite element analysis of non-linear PCL scaffold with Uniform structure  
Table 11 shows the maximum von mises stress for different types of uniform structures (S1, S1.5, S2). 
It can be seen that, similar to mechanical tests, in both tensile and compressive modellings, the 
maximum stress required to deform the structure is reduced by increasing the internal strand sizes of 
the scaffolds, which means a reduction in rigidity of the scaffolds. Fig. 25 shows the deformation of 
the structures in both tensile and compression analyses. 
 
      
 
Fig. 25. (A) 3D CAD simulation of scaffolds with uniform internal structure: tensile (A), compression (B) (Red sections have 
the highest displacement in the structures) – Scale bar=2mm.  
Table 11.Finite Element Analysis of Uniform PCL scaffolds  
A 
S1 S1.5 S2 
B 
S1 S1.5 
S2 
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 Experimental 
Groups 
Strand Size(mm) 
 
Compressive 
Stress(MPa) 
Tensile Stress 
(MPa) 
Uniform internal 
structures 
1 
2 
3 
S1 0.4 6.29 
S1.5 0.31 3.59 
S2 0.23 2.19 
 
3.9.2. Finite element analysis of non-linear PCL scaffold with Non-Uniform structure    
Table 12 shows the maximum von-mises stress for different types of non-uniform structures. The 
results demonstrate that in both tensile and compressive modellings, the maximum stress required to 
deform the structure decreases by increases in strand sizes of the internal structures. Fig. 26 also 
illustrates the deformation of the structures in both tensile and compression analyses. 
 
A 
S2S1 S2S1.5 S2S1.5S1 
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Fig. 26. (A) 3D CAD simulation of scaffolds with non-uniform internal structure: (A) tensile, (B) compression (Red sections 
have the highest displacement in the structures) – Scale bar=2mm.  
Table 12.Finite Element Analysis of Non-Uniform PCL scaffolds 
 Experimental 
Groups 
Strand Size(mm) 
 
Compressive 
Stress(MPa) 
Tensile 
Stress(MPa) 
Non-Uniform 
internal 
structures 
1 
2 
3 
S2S1 0.35  0.488 
S2S1.5 0.26 0.34 
S2S1.5S1 0.11 0.35 
 
3.9.3. Finite element analysis of ear structures with uniform internal structure 
In this section, the ear scaffold was divided into six different sections (Fig. 19 (A)) with a uniform strand 
size of 1 mm. Fig. 27 shows the total deformation of each section under compressive force.  From 
Table 13  in can be seen that the maximum von mises stress in each section is varied because of 
different material density in each section.  
B 
S2S1 S2S1.5 
S2S1.5S1 
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Fig. 27.3D CAD simulation of ear scaffold with uniform internal structure in six different sections (S1) – Scale bar=2mm. 
(Red sections have the highest displacement in the structures). 
Table 13. Elastic modulus on the scaffolds in different areas – Uniform structure 
 Area1 Area2 Area3 Area4 Area5 Area6 
Compressive 
Stress(MPa) 
0.28 0.41 0.22 0.38 0.33 0.35 
 
3.9.4. Finite element analysis of ear structures with non-uniform internal structure 
In this section, a non-uniform ear scaffold with the strand sizes of S1 in sections 1, 2, and 3 and S1.5 
in sections 4, 5, and 6 was modelled (Fig. 19 (A)). As the internal parameters of sections 1, 2, and 3 
were kept to S1, therefore their mechanical properties have not changed and are similar to the 
uniform ear structure. Fig. 28 shows the overall deflection of a non-uniform ear scaffold with strand 
sizes of S1.5 in areas 4, 5, and 6. The maximum von mises stress in each different section is shown in 
Table 14. By comparing Table 13 and Table 14, it can be seen that, the maximum von mises stress of 
non-uniform ear scaffold in the areas 4, 5, and 6 has reduced with the increase in the strand sizes, 
3 
5 
1 2
4
6
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which means less force was needed to deform the structure. From these results it can be concluded 
that by changing the internal properties of the ear structure, its mechanical properties has changed.  
      
Fig. 28.  3D CAD simulation of ear scaffold with non-uniform internal structure (S 1.5 for areas 4, 5, 6) – Scale bar=2mm. 
(Red sections have the highest displacement in the structures). 
Table 14.  Elastic modulus on the scaffolds in different areas – Non-Uniform structure 
 Area4 Area5 Area6 
Compressive 
Stress(MPa) 
0.34 0.28 0.23 
  
In this study the behaviour of the FEA models was assumed to be exactly corresponded with the 
mechanical tests, although the mechanical tests might be different, significantly, from the FEA results. 
The first potential error is presented by the conversion from the CAD into the FEA model; as well as 
possible errors during 3D printing of the scaffolds. Also, in FEA modelling all the test conditions like 
poison’s ratio, temperature, tolerances are assumed to be constant while they might be changing 
during the mechanical tests. Finally, next main reasons for this could be in FEA modelling, the contact 
elements between printed lined are assumed to be fully bonded. However, the actual contact 
parameters between filaments should be measured to be able to get more accurate results in finite 
element analysis.  These issues could be focused on in future studies. Possible errors are concluded 
from the assumptions listed in the section of materials and methods. 
5 4 
6 
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4. Conclusion 
In conclusion, the results show that the mechanical properties of the 3D printed scaffolds, in both 
uniform and non-uniform structures, were affected by the strand sizes of the scaffolds. In other words, 
it was ascertained that, by reducing the distances between strands of the structure, its modulus of 
elasticity increases; which means more force is required to deform the structure. On the other hand, 
by increasing the strand distances, the modulus of elasticity of the structure decreases and less force 
is needed to deform the structure. In addition, it was demonstrated that different zones of a non-
uniform 3D printed scaffold, which have different internal structures, exhibited different mechanical 
properties.   
In FEA analysis, it was also proven that by increasing the strand size of the internal structure, the 
maximum stress required to deform the structure decreases.  
Combining this knowledge with 3D printing technology, made it possible to 3D print an ear structure 
comprised of different zones with different mechanical properties that mimics the human ear.  
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5. Appendix 
5.1. Bioethics  
“Bioethics” is the study of understanding which decisions should be taken with respect to human 
health and people’s lives, giving due consideration to the environment and societal beliefs[41]. In 
bioethics some certain questions about a human’s rights should be answered. Questions like: if certain 
treatments should be done on patients or not, or if these treatments have any positive or negative 
impact on the society or environment. It can also involve issues in people’s lives. For example: should 
a new medicine be tested whether in vitro, on animals, or even on humans. Sometimes In bioethics, 
it requires different types of experts to work on a bioethics issue. Experts in areas like: low, nursing, 
philosophy, etc. So, in conclusion, bioethics is a set of standards for treatment of patients, and to help 
researchers and medical people. Every doctor, nurse or a general health care professional should know 
their patients’ rights and know how to treat them based on medical ethics. On the other hand, every 
patient should know their rights and the power to reject a medical method and, thanks to bioethics, 
these days each patient should know their illness, the length and way that they are going to be cured. 
One of the areas which has many attractions to researchers is Stem cells. These cells are able to 
convert to different types of specific tissues; therefore, they can be used for many patients with little 
chance of cure[42]. Because of the great capabilities of stem cells in medical treatments, a prolific 
growth in the number of stem cell clinics has ensued, however, some of them are involved in illegal 
activities like below[42]: 
• In Hungary, police arrested four people for illegal use of human embryonic stem cells for different 
types of illegal and unlicensed treatments[43]. 
• In Costa Rica, a clinic called Cell Medicine, illegally treated more than 400 foreign patients with 
stem cells for nearly 10 years, and were shut down by the country’s health Ministry because they 
couldn’t provide any scientific proof for their treatments at their clinic. However, after the shut-
down, the Cell medicine clinic continued their business by moving to a bigger place with more 
facilities in Panama City[42]. 
• In 2009, China made a new rule requiring any researcher or clinics working with Stem Cells to 
provide clinical data as well as providing approval from the China health ministry[44]. It is believed 
that China has more than a hundred laboratories working with Stem Cells; which is the largest in 
the world, offering therapies for Multiple Sclerosis, Lupus, Muscular Dystrophy, and spinal cord 
injuries, and is now set to expand to Malaysia, Thailand and the Philippines[45]. 
 
Recently, the use of additive manufacturing (3D Printing) has been used in many innovations such as: 
engineering, art, education, manufacturing and medicine. In medical research, this technology has 
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helped scientists to be able to 3D print biocompatible materials like Multicellular tissues and organs. 
This technology also solve additional difficulties such as types of material, cell types, growing  of cells 
,differentiation factors and other techniques which are impossible to achieve in the current traditional  
transplantation methods [46] New research on regulating 3D printing totally assumes that the same 
regulations  on non-biological materials should be used on biological materials,  nevertheless, these 
two regulations are totally different as printing bio-medical materials presents different public policy 
deliberations [47].  
5.1.1. Researchers and clinicians in developing new therapies 
The main purpose of clinical research is to develop research findings to increase human’s health and 
the comprehension of human’s physiology, behaviour, and other qualities of particular organism or 
class of organisms[42]. For every research done in Australia, it should be corresponded with high 
ethical and scientific standards and therefore the risk of any injury to the participants is low.  
Based on application of the values Section1, it requires any risks to the participants during the research 
to be evaluated, and it will be ethically accepted if the research proves the benefits to the participants 
or good of others[41]. 
Let’s give a short description about risk: Risk is a "danger, hazard; exposure to mischance or risk". 
Hence, to put oneself "at risk" means to contribute voluntarily or involuntarily in an event or activity 
that could cause injury, loss or damage. [The Oxford English Dictionary]. Some involuntary risks are: 
lightning fatality, Fire related accidents, and accidental poisoning. On the other hand voluntary risks 
are like: Automobile accidents, Skydiving accidents[41]. So, to minimise the risk or possibility of 
exploitation, in every research project, it should be assessed, managed, and minimised by the 
researchers and ensuring that the research themes are not only used but adhered to with admiration 
while they contribute to social service [41]. 
The bio-printing research done on bio-printed products involve risk both inside and outside the human 
body and invoke distinctive ethical concerns. For instance, the source of a product which is going to 
be used inside a patient could be an issue in some societies or religions[48].For researchers and clinics 
developing new therapies and medical technologies using bioprinting, it would be so challenging for 
them to be able to test their medicine on real humans (especially in Australia and United states); as 
for example testing of organs and clinical trials to be transplanted in America could take many years 
to get permission from the Food and Drug Administration, whereas it might not take long to get the 
same permission in countries with easier regulations[49]. Unlike non-biological materials, different 
public policy requires to be considered when printing from biological materials. Also, experimenting 
with humans requires compliance with strong political regulatory and ethical debates[50]. 
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5.1.2. Current and future patients in having access to safe, tested and effective 
treatments 
Compared with traditional organ transplantation, there are some advantages for patients using 3D 
printed organs. Bio-printing is having a wide range of benefits with very little risks. It is a big step for 
scientists to be able to help society by printing body parts and saving lives. 3D printed body parts can 
be really helpful, especially where there is a high demand for the parts in the countries with a large 
population or during critical situations like war, and patients do not need to wait for quite a while to 
find a donor. In addition, bio-printed organs can be built customised for each patient and this could 
increase the chance of acceptance of the organ[51]. However, there are some concerns in using this 
emerging technology. For instance, for countries like China and India with large populations and not 
an equal access to health care, having access to this type of treatment could cause imbalanced issues. 
In addition, some bio-printed body parts like the heart could be really expensive and not many people 
can afford them[52]. 
As mentioned before, current bio-printing regulations assume the same regulations that apply for 
other areas of non-biological 3D printing technologies; non-biological parts are ready to be used 
whereas biological parts like hand or leg need to be implanted by surgeons or doctors. Furthermore, 
printing the biological materials requires different public policy factors compared with non-medical 
parts. Also, because bioprinting involves human genetic materials, there is a concern for higher 
security than regular 3D printing[53]. Bio-printing is also different to synthetic biology. Although they 
both should be done by doctors and surgeons, bio-printing is more accessible and requires higher 
certainty than synthetic biology. Furthermore, although organ transplantation and bioprinting 
contains human genetic materials, they do not come from a similar source; transplanted organ comes 
from another human or animals while a bio-printed part comes from the patient’s own genetic source, 
therefore, the possibility of rejection reduces in bio-printing. Thus bio-printing regulations should be 
different to organ transplantation laws[54]. 
As 3D printers and bio-printers can both use the same hardware, almost everyone can have a printer 
in their home and print whatever they want. Therefore, regulating bioprinting requires standards 
instead of rules[55]. The general idea of bioprinting is mostly positive. People are really excited about 
bioprinting issues and its capabilities but, they are intolerant of risk involving any bio-printed parts. 
People usually prefer the ideas that benefit the whole society instead of specific groups of people. 
They prefer that everybody in the society could afford the technology,  and also like to observe the 
evidence of the success of a new drug or device[56].  
 
The method of assessing a novel high-risk device or medicine is different in Europe and United States. 
The European system is relying on safety and execution of the new device or drug while in U.S. 
premarket assessment of safety and performance is necessary which leads to two different clinical 
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cases (Table 15). In Europe, the required evidence of clinical test is lower than what’s needed in 
US[57].  
Table 15. The arrangement of clinical growth and timing of the market presenting new high-risk devices in the US and 
Europe  
Theoretical order over time 
 
Exploratory clinical 
trails 
Confirmatory clinical 
trials (RCTs) 
Health technology 
assessment 
CE mark 
system in 
Europe 
Market presenting 
based on single-arm 
trials demonstrating 
safety and performance 
 
Requires safety and 
efficiency/effectiveness 
data for the 
assessment, that might 
contain an evaluation 
of cost- adequacy 
FDA PMA 
process in 
the US 
 
Market introduction 
depends on RCTs 
demonstrating 
“effectiveness/efficacy” 
and safety  
 
 
In Europe, patients have a choice of having earlier access to a possible curing device or medicine but 
they have to accept any risk of failure (they might also have to pay for any possible costs)[57]. Medical 
devices are classified in both Europe and America based on the chance of harm they cause to patients, 
with class III instruments demonstrating the highest risk class which needs to go through a premarket 
approval process in the United States. In Europe, new high-risk medical devices should be assessed 
through a structure of CE (Conformity European) marking instead of being assessed for a premarket 
review by European Authorities or Member State. This premarket assessment of device is done only 
once for the whole European market. On the other hand, in America the products will also be 
controlled randomly (Randomize control trials (RCTs)) which is the highest standard for recording of 
revealing any increase in efficacy and clinical safety[58]. Also, under Premarket Approval procedure, 
each organization should indicate sensible assurance of the safety and efficacy of its device for its 
desired use[59]. 
5.1.3. Those patients who might be involved as experimental subjects in clinical testing 
One of the main concerns in research ethics is to minimise the amount of participant’s injuries during 
the clinical experiments[60]. However, based on the Nuremburg code, it is assumed that all patients 
are at the risk of injury during medical testings[61]. In addition, the Belmont Report contains the 
necessities for the informed permission of all clinical research contributors[62]. Because bio-printing 
is a kind of new technology, people who are involved in 3D printing experiments might face some 
issues that no one has ever faced. As mentioned above, bio-printing technology is an emerging 
technique in the world, so its results and developments are so interesting for people all around the 
world, so it is a great source for media to follow up. Patients who undergo clinical experiments should 
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be aware of this attention and should be ready physiologically and mentally be ready to deal with. 
Couple of weeks ago I read a news that the world's first face transplant recipient, Frenchwoman 
“Isabelle Dinoire”, died "after a long illness". (6 Sep 2016, the Telegraph News). She lost her face from 
being bitten by her dog which made her to stay at home, but in 2005 she received a chin, nose, and 
lips of a brain-dead donor. Although this transplantation gave her a new life and enabled her to talk 
and go out without feeling different to other people, but as the first human who received a facial 
transplant, she was always under a lot of attention by media which made her uncomfortable and 
eventually depressed! Bio-printing can also be used in emergency situations for patients who lose a 
body part in an accident or war. Imagine a bike rider who loses his leg in a car accident, his leg can be 
modelled by taking a MRI picture of the other leg, mirroring it and printing, isn’t this fabulous?  Or 
assume a baby who is born with only one ear, the other ear can be scanned, printed, and finally 
implanted for him/her, and the kid can continue to have a normal life without being scared of being 
bullied at school. 
On the other hand, this technology can’t be accepted by everyone easily. There are some religions 
who do not believe in using of any external part in their body. For example, in a situation where a guy 
with this belief losing his kidney and there is no donor and the guy will lose his life if he does not get 
one within 24 hrs, the surgeons are able to print the kidney using cells that they got from a donor. If 
this guy accepts the new kidney, he should always think about this issue of whether this external 
subject is accepted in his religion or not. In addition, in bio-printing, the material and source of them 
should be specified as well. For instance, in Islam men are advised not to wear gold, so printing a gold 
bone for a male patient with Islamic beliefs can cause some conflicts for him. 
Although 3D printing of human organs can be very good in medical conditions, however, one of the 
main considerations in 3D printing body parts is that whether we should use a 3D printer for human 
organs improvements. This technology can be used to improve the human’s power and capabilities. 
For instance, metal bones can be printed and replaced for human bone which can be 3 times stronger. 
Also, imagine printing stronger muscles which could give humans much more power. Although this 
sounds really interesting and can be useful in many respects, it can cause a lot of problems if the 
technology gets abused by some people. For instance, imagine if athletes use these 3D printed muscles 
in their competition, so running in an Olympics could be meaningless! There would be a competition 
between technologies instead of humans. 
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